JAGSONPAL PHARMACEUTICALS LTD. Q2 FY26 Results
JAGSNPHARMQ2 FY26 ResultsAnnounced 3 Nov 2025, 05:28 pm| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 74.47 | 1.5% | 0.3% |
| Total Income | 77.49 | 1.2% | 1.5% |
| Expenditure | 60.68 | 5.2% | 0.5% |
| PBT | 16.81 | 16.5% | 9.4% |
| Net Profit | 12.57 | 16.5% | 9.7% |
| OPM | 22.07% | 3.27pp | 7.15pp |
| NPM | 16.23% | 2.47pp | 1.22pp |
| EPS | 1.88 | 17.5% | 56.2% |
Jagsonpal Pharmaceuticals Ltd Announces Q2 and H1 Results for FY2025-26, Net Profit at INR 167.88 Million
03 Nov 2025 · 3 Nov 2025, 05:33 pm
Summary
Jagsonpal Pharmaceuticals Ltd has announced its Q2 and H1 results for the financial year 2025-26. The company's net profit stands at INR 167.88 Million. The financial results have been reviewed by Walker Chandiok & Co LLP, the statutory auditors of the company.
Key Highlights
- 1
Revenue from operations for the quarter ended 30 September 2025 is Rs. 2,769.06 Million
- 2
Profit before tax for the quarter ended 30 September 2025 is Rs. 168.10 Million
- 3
Current tax expense for the quarter ended 30 September 2025 is Rs. 38.07 Million
- 4
Net profit for the quarter ended 30 September 2025 is Rs. 167.88 Million
- 5
Paid-up equity share capital is Rs. 133.27 Million with a face value of Rs. 2 per share
Management Comments
Not provided
The management comments are not provided in the document.
Informational and educational content only. Not investment advice.